These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8892780)

  • 1. New diagnostic options in hypertrophic cardiomyopathy.
    Posma JL; van der Wall EE; Blanksma PK; van der Wall E; Lie KI
    Am Heart J; 1996 Nov; 132(5):1031-41. PubMed ID: 8892780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vector flow mapping in obstructive hypertrophic cardiomyopathy to assess the relationship of early systolic left ventricular flow and the mitral valve.
    Ro R; Halpern D; Sahn DJ; Homel P; Arabadjian M; Lopresto C; Sherrid MV
    J Am Coll Cardiol; 2014 Nov; 64(19):1984-95. PubMed ID: 25440093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early changes in apical rotation in genotype positive children with hypertrophic cardiomyopathy mutations without hypertrophic changes on two-dimensional imaging.
    Forsey J; Benson L; Rozenblyum E; Friedberg MK; Mertens L
    J Am Soc Echocardiogr; 2014 Feb; 27(2):215-21. PubMed ID: 24325958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between left ventricular outflow tract obstruction and left ventricular shape in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study.
    Martin R; Lairez O; Boudou N; Méjean S; Lhermusier T; Dumonteil N; Berry M; Cognet T; Massabuau P; Elbaz M; Rousseau H; Galinier M; Carrié D
    Arch Cardiovasc Dis; 2013; 106(8-9):440-7. PubMed ID: 23906680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term beat-to-beat variability of the QT interval is increased and correlates with parameters of left ventricular hypertrophy in patients with hypertrophic cardiomyopathy.
    Orosz A; Baczkó I; Nagy V; Gavallér H; Csanády M; Forster T; Papp JG; Varró A; Lengyel C; Sepp R
    Can J Physiol Pharmacol; 2015 Sep; 93(9):765-72. PubMed ID: 26313025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of intra-left ventricular electromechanical asynchrony in patients with mild hypertrophic cardiomyopathy compared with power athletes.
    D'Andrea A; Caso P; Cuomo S; Salerno G; Scarafile R; Mita C; De Corato G; Sarubbi B; Scherillo M; Calabrò R
    Br J Sports Med; 2006 Mar; 40(3):244-50; discussion 244-50. PubMed ID: 16505082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of left ventricular systolic and diastolic abnormalities in patients with hypertrophic cardiomyopathy using real-time three-dimensional echocardiography and two-dimensional speckle tracking imaging.
    Huang X; Yue Y; Wang Y; Deng Y; Liu L; Di Y; Sun S; Chen D; Fan L; Cao J
    Cardiovasc Ultrasound; 2018 Oct; 16(1):23. PubMed ID: 30285887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High throughput phenotyping of left and right ventricular cardiomyopathy in calcineurin transgene mice.
    Moreth K; Afonso LC; Fuchs H; Gailus-Durner V; Katus HA; Bekeredjian R; Lehman L; Hrabě de Angelis M
    Int J Cardiovasc Imaging; 2015 Apr; 31(4):669-79. PubMed ID: 25627778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apical hypertrophic cardiomyopathy with left ventricular apical aneurysm: Importance of multi-modality imaging.
    Kherada N; Vinardell JM; Mihos CG; Santana O
    Echocardiography; 2017 Sep; 34(9):1392-1395. PubMed ID: 28573739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of cardiac sympathetic nerve activity and systolic dysfunction in patients with hypertrophic cardiomyopathy.
    Shimizu M; Ino H; Yamaguchi M; Terai H; Hayashi K; Nakajima K; Taki J; Mabuchi H
    J Nucl Med; 2002 Jan; 43(1):15-20. PubMed ID: 11801697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertrophic cardiomyopathy: an updated review on diagnosis, prognosis, and treatment.
    Makavos G; Κairis C; Tselegkidi ME; Karamitsos T; Rigopoulos AG; Noutsias M; Ikonomidis I
    Heart Fail Rev; 2019 Jul; 24(4):439-459. PubMed ID: 30852773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systolic function reserve using two-dimensional strain imaging in hypertrophic cardiomyopathy: comparison with essential hypertension.
    Badran HM; Faheem N; Ibrahim WA; Elnoamany MF; Elsedi M; Yacoub M
    J Am Soc Echocardiogr; 2013 Dec; 26(12):1397-406. PubMed ID: 24094559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The electrocardiogram as a diagnostic tool for hypertrophic cardiomyopathy: revisited.
    Maron BJ
    Ann Noninvasive Electrocardiol; 2001 Oct; 6(4):277-9. PubMed ID: 11686906
    [No Abstract]   [Full Text] [Related]  

  • 14. Left ventricular mechanical dispersion is associated with nonsustained ventricular tachycardia in hypertrophic cardiomyopathy.
    Jalanko M; Tarkiainen M; Sipola P; Jääskeläinen P; Lauerma K; Laine M; Nieminen MS; Laakso M; Heliö T; Kuusisto J
    Ann Med; 2016 Sep; 48(6):417-427. PubMed ID: 27249556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitral annular plane systolic excursion is an easy tool for fibrosis detection by late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Doesch C; Sperb A; Sudarski S; Lossnitzer D; Rudic B; Tülümen E; Heggemann F; Schimpf R; Schoenberg SO; Borggrefe M; Papavassiliu T
    Arch Cardiovasc Dis; 2015; 108(6-7):356-66. PubMed ID: 25863428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening.
    Basavarajaiah S; Wilson M; Whyte G; Shah A; McKenna W; Sharma S
    J Am Coll Cardiol; 2008 Mar; 51(10):1033-9. PubMed ID: 18325444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic expression in hypertrophic cardiomyopathy and late gadolinium enhancement on cardiac magnetic resonance.
    Caetano F; Botelho A; Trigo J; Silva J; Almeida I; Venâncio M; Pais J; Sanches C; Leitão Marques A
    Rev Port Cardiol; 2014 May; 33(5):261-7. PubMed ID: 24909443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complementary Role of Echocardiography and Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy.
    Hindieh W; Chan R; Rakowski H
    Curr Cardiol Rep; 2017 Sep; 19(9):81. PubMed ID: 28752280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac imaging and stress testing asymptomatic athletes to identify those at risk of sudden cardiac death.
    La Gerche A; Baggish AL; Knuuti J; Prior DL; Sharma S; Heidbuchel H; Thompson PD
    JACC Cardiovasc Imaging; 2013 Sep; 6(9):993-1007. PubMed ID: 24029371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Biomarkers of Myocardial Remodeling and Coronary Dysfunction in Early Stages of Hypertrophic Cardiomyopathy in the Young.
    Fernlund E; Gyllenhammar T; Jablonowski R; Carlsson M; Larsson A; Ärnlöv J; Liuba P
    Pediatr Cardiol; 2017 Apr; 38(4):853-863. PubMed ID: 28361263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.